BMRA
BMRA
NASDAQ · Health Care

Biomerica Inc

$2.39
+0.07 (+3.01%)
As of Sep 28, 10:43 PM ET ·
Financial Highlights (FY 2026)
Revenue
7.10M
Net Income
-6,020,023
Gross Margin
8.1%
Profit Margin
-84.8%
Rev Growth
-5.9%
D/E Ratio
0.19
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 8.1% 8.1% 51.4% 51.4%
Operating Margin -119.5% -107.5% 10.2% 10.6%
Profit Margin -84.8% -80.5% 7.4% 6.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 7.10M 7.54M 4.51M 3.72M
Gross Profit 577.3K 613.4K 2.32M 1.91M
Operating Income -8,483,827 -8,112,456 460.4K 394.0K
Net Income -6,020,023 -5,756,503 334.1K 231.1K
Gross Margin 8.1% 8.1% 51.4% 51.4%
Operating Margin -119.5% -107.5% 10.2% 10.6%
Profit Margin -84.8% -80.5% 7.4% 6.2%
Rev Growth -5.9% -5.9% +23.6% -7.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 861.3K 861.3K 948.7K 899.3K
Total Equity 4.53M 4.53M 4.87M 5.15M
D/E Ratio 0.19 0.19 0.19 0.17
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -8,360,911 -8,439,083 633.7K 568.5K
Free Cash Flow — — 271.4K 245.7K